Literature DB >> 23408089

High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection.

Cindy Strehl1, Timo Gaber, Manuela Jakstadt, Martin Hahne, Paula Hoff, Cornelia M Spies, Alexander Scheffold, Gerd-Rüdiger Burmester, Frank Buttgereit.   

Abstract

Flow cytometry has become a widely-used and powerful tool for the characterization of cells according to their expression of specific proteins. However, sensitivity of this method is still limited since conventionally labeled antibodies can be conjugated with at maximum 1-10 dye molecules. This fact resulted in the need to develop new techniques in order to identify molecules which are expressed in very low but functionally relevant amounts. In the past, we have successfully used a liposome-based high-sensitivity immunofluorescence technique to measure the expression of low abundant membrane bound glucocorticoid receptors (mGR) on different cell types. The use of this technique allows the detection of as few as 50-100 antigen molecules per cell which is due to a 100-fold to 1000-fold increase in fluorescence signal intensity compared with conventional methods. The higher sensitivity is achieved since thousands of dye molecules can be enclosed in liposomes. Another modern high-sensitivity immunofluorescence staining method is the purchasable Fluorescence Amplification by Sequential Employment of Reagents (FASER) procedure. Here, we aimed at comparing sensitivity and specificity of these two techniques for the detection of the mGR. Our data demonstrate the FASER technique to be more sensitive and also more specific for the detection of mGR as compared to the liposome technique. However, both methods have advantages and disadvantages which are discussed in detail.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408089     DOI: 10.1007/s10895-013-1163-4

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  39 in total

1.  Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice.

Authors:  Désirée Kunkel; Dennis Kirchhoff; Shin-Ichi Nishikawa; Andreas Radbruch; Alexander Scheffold
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

Review 2.  Non-genomic glucocorticoid effects to provide the basis for new drug developments.

Authors:  In-Ho Song; Frank Buttgereit
Journal:  Mol Cell Endocrinol       Date:  2006-01-18       Impact factor: 4.102

Review 3.  Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.

Authors:  Mark Löwenberg; Cindy Stahn; Daniel W Hommes; Frank Buttgereit
Journal:  Steroids       Date:  2007-12-14       Impact factor: 2.668

4.  Cell cycle regulation of membrane glucocorticoid receptor in CCRF-CEM human ALL cells: correlation to apoptosis.

Authors:  F N Sackey; C S Watson; B Gametchu
Journal:  Am J Physiol       Date:  1997-09

Review 5.  Antigen presentation.

Authors:  E R Unanue; J C Cerottini
Journal:  FASEB J       Date:  1989-11       Impact factor: 5.191

6.  The minimal number of class II MHC-antigen complexes needed for T cell activation.

Authors:  S Demotz; H M Grey; A Sette
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

7.  The T-cell accessory molecule CD4 recognizes a monomorphic determinant on isolated Ia.

Authors:  D Gay; S Buus; J Pasternak; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway.

Authors:  C M Spies; D H S Schaumann; T Berki; K Mayer; M Jakstadt; D Huscher; C Wunder; G-R Burmester; A Radbruch; R Lauster; A Scheffold; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2006-01-31       Impact factor: 19.103

9.  Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody.

Authors:  T Berki; G Kumánovics; A Kumánovics; A Falus; E Ujhelyi; P Németh
Journal:  J Immunol Methods       Date:  1998-05-01       Impact factor: 2.303

10.  CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo.

Authors:  Karin Knieke; Holger Hoff; Frank Maszyna; Paula Kolar; Arnhild Schrage; Alf Hamann; Gudrun F Debes; Monika C Brunner-Weinzierl
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.